CXCL12 and pancreatic neoplasm: Furthermore, the IL-6 autocrine loop, facilitated by Akt and ERK signaling pathway activation, contributes to CXCL12-induced gemcitabine chemoresistance in pancreatic cancer cells (Zhang et al., 2015).